Trial Outcomes & Findings for Mindful Stress Reduction in Diabetes Self-management Education for Veterans (NCT NCT02928952)
NCT ID: NCT02928952
Last Updated: 2021-05-28
Results Overview
A 20-item psychometrically validated self-report questionnaire on a 5 point Likert scale (0= not problem; 4= a serious problem). The scores are summed and multiplied by 1.25. Minimum value = 0; Maximum value = 100. Higher scores denote higher levels of diabetes related distress. The cutoff for significant distress is 33; a score of 40 is consistent with diabetes burn-out.
COMPLETED
NA
132 participants
baseline, 12 weeks and 24 weeks
2021-05-28
Participant Flow
Dates of recruitment: 11-1-2016 to 10-31-2019 Diabetes outpatient clinic at VA Pittsburgh Healthcare System, Oakland campus
One participant was excluded because of concomitant enrollment in a similar study that could have confounded results.
Participant milestones
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
Usual care control
|
|---|---|---|
|
Overall Study
STARTED
|
65
|
67
|
|
Overall Study
COMPLETED
|
55
|
60
|
|
Overall Study
NOT COMPLETED
|
10
|
7
|
Reasons for withdrawal
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
Usual care control
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
5
|
5
|
|
Overall Study
Withdrawal by Subject
|
5
|
1
|
|
Overall Study
Physician Decision
|
0
|
1
|
Baseline Characteristics
Mindful Stress Reduction in Diabetes Self-management Education for Veterans
Baseline characteristics by cohort
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
Total
n=132 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
60.6 years
STANDARD_DEVIATION 10.5 • n=93 Participants
|
60.7 years
STANDARD_DEVIATION 10.8 • n=4 Participants
|
60.7 years
STANDARD_DEVIATION 10.6 • n=27 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=93 Participants
|
6 Participants
n=4 Participants
|
11 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
60 Participants
n=93 Participants
|
61 Participants
n=4 Participants
|
121 Participants
n=27 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Black or African American
|
20 Participants
n=93 Participants
|
23 Participants
n=4 Participants
|
43 Participants
n=27 Participants
|
|
Race (NIH/OMB)
White
|
45 Participants
n=93 Participants
|
44 Participants
n=4 Participants
|
89 Participants
n=27 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Region of Enrollment
United States
|
65 Participants
n=93 Participants
|
67 Participants
n=4 Participants
|
132 Participants
n=27 Participants
|
|
Living with partner
|
26 Participants
n=93 Participants
|
31 Participants
n=4 Participants
|
57 Participants
n=27 Participants
|
|
Post-High School Education
|
54 Participants
n=93 Participants
|
52 Participants
n=4 Participants
|
106 Participants
n=27 Participants
|
|
Employment Status- working full or part time
|
18 Participants
n=93 Participants
|
14 Participants
n=4 Participants
|
32 Participants
n=27 Participants
|
|
Diabetes Phenotype-type 2 diabetes
|
62 Participants
n=93 Participants
|
62 Participants
n=4 Participants
|
124 Participants
n=27 Participants
|
|
Charlson Co-Morbidity Index (CMI)
|
4.31 units on a scale
STANDARD_DEVIATION 141 • n=93 Participants
|
4.33 units on a scale
STANDARD_DEVIATION 1.79 • n=4 Participants
|
4.32 units on a scale
STANDARD_DEVIATION 1.61 • n=27 Participants
|
|
Insulin use
|
46 Participants
n=93 Participants
|
47 Participants
n=4 Participants
|
93 Participants
n=27 Participants
|
|
Duration of Diabetes
|
12.09 years
STANDARD_DEVIATION 9.67 • n=93 Participants
|
13.81 years
STANDARD_DEVIATION 11.05 • n=4 Participants
|
12.96 years
STANDARD_DEVIATION 10.39 • n=27 Participants
|
PRIMARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Numbers analyzed differ among rows from the overall number analyzed because of attrition and missed visits.
A 20-item psychometrically validated self-report questionnaire on a 5 point Likert scale (0= not problem; 4= a serious problem). The scores are summed and multiplied by 1.25. Minimum value = 0; Maximum value = 100. Higher scores denote higher levels of diabetes related distress. The cutoff for significant distress is 33; a score of 40 is consistent with diabetes burn-out.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Problem Areas in Diabetes Scale (PAID) -(Measures Diabetes Distress)
Baseline
|
27.58 units on a scale
Standard Deviation 15.41
|
31.24 units on a scale
Standard Deviation 16.72
|
|
Problem Areas in Diabetes Scale (PAID) -(Measures Diabetes Distress)
12 weeks
|
17.00 units on a scale
Standard Deviation 13.10
|
20.83 units on a scale
Standard Deviation 13.32
|
|
Problem Areas in Diabetes Scale (PAID) -(Measures Diabetes Distress)
24 weeks
|
12.89 units on a scale
Standard Deviation 11.30
|
21.15 units on a scale
Standard Deviation 13.02
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Statistical Test of hypothesis. Differing sample sizes are due to attrition and missed research visits. Analyzed as intention to treat in mixed models with imputation as last value moved forward.
An 8-item psychometrically validated self-report questionnaire on a 10- point Likert Scale (1= Not confident at all; 10 = Totally confident). This scale measures diabetes self efficacy, a critical pathway to improved self-management that refers to an individual's confidence in their ability to perform key diabetes self-management behaviors. Scores are derived as the mean of the 8 questions. Minimum score =1; Maximum Score = 10. Higher scores denote higher diabetes self-efficacy.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Diabetes Self-efficacy Scale (DSES)
Baseline
|
6.20 score on a scale
Standard Deviation 1.94
|
5.77 score on a scale
Standard Deviation 1.95
|
|
Diabetes Self-efficacy Scale (DSES)
12 weeks
|
6.97 score on a scale
Standard Deviation 1.91
|
6.40 score on a scale
Standard Deviation 1.80
|
|
Diabetes Self-efficacy Scale (DSES)
24 weeks
|
7.26 score on a scale
Standard Deviation 2.10
|
6.47 score on a scale
Standard Deviation 1.92
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed research assessment, missed visit or failure to go to the lab to have bloodwork done following the research assessment. Three participant in the intervention group and 2 participants in the DSME-alone group did not have A1C done following the 24 week assessment related to closure of the outpatient lab due to COVID-19. Analyzed as intention to treat with imputation moving last value forward.
A blood test that measures the percentage of glycated hemoglobin in red blood cells as a means of estimating the average blood sugar concentrations for the preceding two to three months. Lower percentage denote better blood glucose levels and may range from 4.5% in persons without diabetes t0 \>15% in persons with poorly managed hyperglycemia. . An A1C \<7% has been associated with prevention of diabetes complications. A1C\>9% denotes chronic,severe blood glucose elevation. All tests were performed at VAPHS according to National Glyco-hemoglobin Standardization Program-approved methods.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Hemoglobin A1c (A1C)
Baseline
|
8.57 percentage of glycated Hemoglobin
Standard Deviation 1.49
|
8.68 percentage of glycated Hemoglobin
Standard Deviation 1.63
|
|
Hemoglobin A1c (A1C)
12 weeks
|
7.87 percentage of glycated Hemoglobin
Standard Deviation 1.23
|
7.94 percentage of glycated Hemoglobin
Standard Deviation 1.22
|
|
Hemoglobin A1c (A1C)
24 weeks
|
7.84 percentage of glycated Hemoglobin
Standard Deviation 1.38
|
8.09 percentage of glycated Hemoglobin
Standard Deviation 1.51
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition and missed or abbreviated visit. One participant had to leave the 24 week visit after completing just 3 of the questionnaires and before completing the other questionnaires. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis since 3 assessments including the primary outcome assessment were completed. Analyzed as intention to treat with imputation moving last value forward.
A 15-item psychometrically validated questionnaire on a 6-point Likert scale (1=Almost Always and 6= Never) The scale is scored by computing the mean of the 15 items. (Minimum score = 1; maximum score = 6). Higher scores reflect higher levels of dispositional (trait) mindfulness. Average score in the general US population is 4.22. Mindfulness is a mental state achieved by focusing one's awareness on the present moment, while calmly acknowledging and accepting one's feelings, thoughts, and bodily sensations.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Mindfulness Attention and Awareness Scale (MAAS)
Baseline
|
4.37 score on a scale
Standard Deviation 0.93
|
4.25 score on a scale
Standard Deviation 0.85
|
|
Mindfulness Attention and Awareness Scale (MAAS)
12 weeks
|
4.49 score on a scale
Standard Deviation 0.96
|
4.42 score on a scale
Standard Deviation 0.85
|
|
Mindfulness Attention and Awareness Scale (MAAS)
24 weeks
|
4.52 score on a scale
Standard Deviation 1.04
|
4.47 score on a scale
Standard Deviation 0.96
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition or missed visit. Analyzed as intention to treat with imputation moving last value forward.
Weight in pounds
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Body Weight
Baseline
|
227.80 Pounds
Standard Deviation 40.14
|
233.64 Pounds
Standard Deviation 50.15
|
|
Body Weight
12 weeks
|
229.16 Pounds
Standard Deviation 38.97
|
231.24 Pounds
Standard Deviation 48.29
|
|
Body Weight
24 weeks
|
229.63 Pounds
Standard Deviation 38.92
|
231.04 Pounds
Standard Deviation 49.53
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed visit or shortened visit. Two participants did not have their BP taken at week 24 due to social distancing and COVID-19 precautions. Analyzed as intention to treat with imputation moving last value forward.
Change in mean arterial blood pressure, calculated as blood pressure + 2 (diastolic blood pressure) divided by 3.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Blood Pressure
24 weeks
|
99.61 mmHg
Standard Deviation 13.90
|
96.85 mmHg
Standard Deviation 13.51
|
|
Blood Pressure
Baseline
|
99.46 mmHg
Standard Deviation 12.04
|
100.26 mmHg
Standard Deviation 13.59
|
|
Blood Pressure
12 weeks
|
98.51 mmHg
Standard Deviation 13.02
|
95.77 mmHg
Standard Deviation 13.82
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed visit or missed assessments.One participant had to leave the 24 week visit after completing just 3 of the questionnaires. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis since 3 assessments including the primary outcome assessment (PAID) were completed. Analyzed as intention to treat with imputation moving last value forward.
The Patient Health Questionnaire (PHQ-8) is a standardized, validated scale that assesses 8 key symptoms of depression experienced over the prior two weeks on a 4-point Likert scale (0=not at all; 3= nearly every day). It is the same as the PHQ-9, without the question regarding suicidal ideation. Score is the sum of the 8 items (Minimum value =0; Maximum= 24). A score of 10 or greater is considered major depression, 20 or more is severe major depression.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Patient Health Questionnaire (PHQ8)
24 weeks
|
5.61 score on a scale
Standard Deviation 5.46
|
7.20 score on a scale
Standard Deviation 4.79
|
|
Patient Health Questionnaire (PHQ8)
Baseline
|
8.22 score on a scale
Standard Deviation 5.66
|
9.07 score on a scale
Standard Deviation 5.78
|
|
Patient Health Questionnaire (PHQ8)
12 weeks
|
5.98 score on a scale
Standard Deviation 5.05
|
6.97 score on a scale
Standard Deviation 4.96
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed or incomplete assessments. One participant left the 24- week visit early after completing just 3 of the questionnaires. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis since 3 assessments including that for the primary outcome assessment were completed. Analyzed as intention to treat with imputation moving last value forward.
The Abbreviated PCL-C is a validated 6-item civilian version of the PTSD check- list designed for use in general medical settings to assess symptoms of PTSD using a 5-point Likert scale. Scores reflect how much the participant has been bothered by specific PTSD symptoms during the past month. (0= "not at all; 4= "extremely") .Scores are summed. (Minimum value =0; maximum values = 24). Scores \>14 are suggestive of PTSD, with higher scores reflecting greater PTSD symptoms.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
PTSD Checklist- Civilian Version (PCL-C)
Baseline
|
13.22 score on a scale
Standard Deviation 5.71
|
13.90 score on a scale
Standard Deviation 5.69
|
|
PTSD Checklist- Civilian Version (PCL-C)
12 weeks
|
11.63 score on a scale
Standard Deviation 4.87
|
12.49 score on a scale
Standard Deviation 5.15
|
|
PTSD Checklist- Civilian Version (PCL-C)
24 weeks
|
11.09 score on a scale
Standard Deviation 5.71
|
12.62 score on a scale
Standard Deviation 5.03
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition or missed visit.
A 2-item subscale of the psychometrically validated SDSCA that measures the frequency of general dietary behaviors each day over the past 7-days and number of days per week over the past month (0= no days; 7 = 7 days). Scores = mean number of days per week ( Minimum score =0; maximum score = 7) . Higher scores denote healthier dietary behaviors.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA), General Diet
Baseline
|
3.25 score on a scale
Standard Deviation 2.07
|
3.51 score on a scale
Standard Deviation 1.90
|
|
Summary of Diabetes Self-Care Activities (SDSCA), General Diet
12 week
|
4.60 score on a scale
Standard Deviation 1.83
|
4.20 score on a scale
Standard Deviation 1.51
|
|
Summary of Diabetes Self-Care Activities (SDSCA), General Diet
24 weeks
|
4.93 score on a scale
Standard Deviation 1.51
|
3.88 score on a scale
Standard Deviation 1.86
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Differing sample sizes are due to attrition and missed research visits.
A 2-item subscale of the psychometrically validated SDSCA that measures the frequency of eating fruits and vegetables and high fat foods each day over the past 7-days. Minimum maximum values = (0= no days; 7 = 7 days). 1 item is scored as mean number of days (Minimum score =0; maximum score = 7), while the 2nd item is summed and reversed (0= 7days; 7= 0 days). The scores for the two items are summed for the subscale score (Minimum score=0; maximum score =7) Higher scores denote healthier dietary behaviors. Each subscale of the SDSCA is scored separately, without a calculated composite score.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=66 Participants
Usual care control
|
|---|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA), Specific Diet
12 weeks
|
3.71 score on a scale
Standard Deviation 1.39
|
3.57 score on a scale
Standard Deviation 1.39
|
|
Summary of Diabetes Self-Care Activities (SDSCA), Specific Diet
Baseline
|
3.28 score on a scale
Standard Deviation 1.62
|
2.97 score on a scale
Standard Deviation 3.57
|
|
Summary of Diabetes Self-Care Activities (SDSCA), Specific Diet
24 weeks
|
4.01 score on a scale
Standard Deviation 1.40
|
3.55 score on a scale
Standard Deviation 1.45
|
SECONDARY outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Differing sample sizes are due to attrition and missed research visits.
One item from the SDSCA that assesses the number of days over the past 7-days in which the participant spaced carbohydrates evenly throughout the day. Minimum score 0; maximum score 7. Higher scores denote healthier dietary behaviors.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA) Space Carbohydrates
Baseline
|
2.91 score on a scale
Standard Deviation 2.45
|
2.64 score on a scale
Standard Deviation 2.04
|
|
Summary of Diabetes Self-Care Activities (SDSCA) Space Carbohydrates
12 weeks
|
3.76 score on a scale
Standard Deviation 1.95
|
3.51 score on a scale
Standard Deviation 2.17
|
|
Summary of Diabetes Self-Care Activities (SDSCA) Space Carbohydrates
24 weeks
|
4.42 score on a scale
Standard Deviation 1.99
|
3.43 score on a scale
Standard Deviation 2.28
|
SECONDARY outcome
Timeframe: baseline, 12 weeks, 24 weeksPopulation: Differing sample sizes are due to attrition and missed research visits.
A 2-item subscale of the SDSCA that measures the number of days over the past 7-days on which the participant engaged in physical activity . Score = mean score of days over the past 7 days (Min.=1; Max.=7). Higher scores denote healthier exercise behaviors. Each SDSCA subscale scored separately.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA)- Exercise
Baseline
|
2.82 score on a scale
Standard Deviation 2.09
|
2.49 score on a scale
Standard Deviation 2.06
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- Exercise
12 weeks
|
3.04 score on a scale
Standard Deviation 2.24
|
3.02 score on a scale
Standard Deviation 2.33
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- Exercise
24 weeks
|
3.31 score on a scale
Standard Deviation 2.10
|
3.09 score on a scale
Standard Deviation 2.31
|
SECONDARY outcome
Timeframe: baseline, 12 weeks, 24 weeksPopulation: Differing sample sizes are due to attrition and missed research visits.
A 2-item subscale of the SDSCA that measures the number of days the participant 1) inspected their feet and 2) inspected the inside of their shoes over the past 7-days. Score = mean number of days (Min=0; max=7). Higher scores denote healthier footcare behaviors.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Footcare
Baseline
|
3.57 score on a scale
Standard Deviation 2.30
|
4.04 score on a scale
Standard Deviation 2.42
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Footcare
12 weeks
|
4.58 score on a scale
Standard Deviation 2.18
|
4.81 score on a scale
Standard Deviation 2.13
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Footcare
24 weeks
|
4.70 score on a scale
Standard Deviation 2.25
|
4.85 score on a scale
Standard Deviation 2.21
|
SECONDARY outcome
Timeframe: baseline, 12 weeks, 24 weeksPopulation: Differing sample sizes are due to attrition and missed research visits or skipped questionnaires. One person in each group did not complete the questionnaire at baseline because they were not prescribed blood glucose monitoring by their diabetes care providers.
A 2-item subscale of the SDSCA that measures 1) the number of days on which the participant tested their blood glucose over the past 7 days and 2) the number of days on which they tested their blood glucose according to the number of times recommended by their health care provider over the past 7-days. Scores= mean number of days per week. Minimum score is 0 Maximum score is 7.Higher scores denote healthier self-monitoring behaviors. Each SDSCA subscale scored separately
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=64 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=66 Participants
Usual care control
|
|---|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA)- Blood Glucose Testing
12 weeks
|
5.00 score on a scale
Standard Deviation 2.50
|
4.92 score on a scale
Standard Deviation 2.19
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- Blood Glucose Testing
24 weeks
|
5.19 score on a scale
Standard Deviation 2.33
|
4.56 score on a scale
Standard Deviation 2.53
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- Blood Glucose Testing
Baseline
|
4.68 score on a scale
Standard Deviation 2.71
|
4.94 score on a scale
Standard Deviation 2.54
|
SECONDARY outcome
Timeframe: baseline,12 weeks, 24 weeksPopulation: Differing sample sizes are due to attrition and missed research visits or incomplete assessment. Two participants in the DSME + Mind-STRIDE intervention group did not complete the Smoking subset of the SDSCA because they do not smoke.
A 2-item subscale of the SDSCA that measures 1) whether the participant smoked even a puff of a cigarette in the past 7 days (0=no; 1= yes) and 2) if so, the number of cigarettes smoked on an average day. The scores are summed. Minimum score =0, maximum score = \>40. Lower scores denote healthier smoking behaviors.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=63 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Smoking
Baseline
|
2.82 score on a scale
Standard Deviation 5.79
|
2.69 score on a scale
Standard Deviation 6.14
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Smoking
12 weeks
|
2.13 score on a scale
Standard Deviation 5.65
|
3.03 score on a scale
Standard Deviation 6.52
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Smoking
24 weeks
|
2.12 score on a scale
Standard Deviation 6.45
|
2.83 score on a scale
Standard Deviation 6.74
|
SECONDARY outcome
Timeframe: baseline, 12 weeks, 24 weeksPopulation: Differing sample sizes are due to attrition, missed research visits or missing assessment questions. One person in Usual Care Control Group did not take any diabetes medications as reflected in the overall number of participants analyzed in that group.
A 2-item subscale of the SDCSA that measures the frequency of 1) taking prescribed insulin and 2)prescribed number of diabetes pills each day over the past 7-days. Scores from the 2 items are summed. Minimum score =0; maximum score = 7). Higher scores denote greater adherence to diabetes medications. Participants entered N/A if they were not prescribed insulin or diabetes pills. Each subscale of the SDSCA is scored independently with no calculated composite score.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=66 Participants
Usual care control
|
|---|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Medication Adherence
Baseline
|
6.49 score on a scale
Standard Deviation 1.17
|
6.30 score on a scale
Standard Deviation 1.50
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Medication Adherence
12 weeks
|
6.28 score on a scale
Standard Deviation 1.79
|
6.02 score on a scale
Standard Deviation 1.76
|
|
Summary of Diabetes Self-Care Activities (SDSCA)- - Medication Adherence
24 weeks
|
6.45 score on a scale
Standard Deviation 1.52
|
6.28 score on a scale
Standard Deviation 1.60
|
OTHER_PRE_SPECIFIED outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed visits, or skipped assessments. One participant had to leave the 24 week before completing the Pain Interference assessment. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis because he completed 3 of the other assessments including the primary outcome assessment.. Analyzed as intention to treat with imputation moving last value forward.
A psychometrically validated 7-item instrument on a 5 point Likert scale (1= "not at all"- 5 and "very much") determining the degree to which pain has interfered with aspects of daily living during the past 7 days. It is a general and not disease-specific measure of pain. Scores are summed (Min. value = 6; Max value =35). Total raw scores are then converted into a T-score for each participant. The T-scores rescales the raw score into a standardized score with a mean of 50 and a standard deviation of 10. A score of 50 is the average for the United States general population with a standard deviation of 10.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Change in 6-item PROMIS Short Form v1.0 Pain Interference 6 b
Baseline
|
56.68 score on a scale
Standard Deviation 9.30
|
58.52 score on a scale
Standard Deviation 8.64
|
|
Change in 6-item PROMIS Short Form v1.0 Pain Interference 6 b
12 weeks
|
54.66 score on a scale
Standard Deviation 9.22
|
57.08 score on a scale
Standard Deviation 8.78
|
|
Change in 6-item PROMIS Short Form v1.0 Pain Interference 6 b
24 weeks
|
53.97 score on a scale
Standard Deviation 10.29
|
56.84 score on a scale
Standard Deviation 8.31
|
OTHER_PRE_SPECIFIED outcome
Timeframe: baseline, 12 weeks and 24 weeksPopulation: Number analyzed differs in one or more rows from overall number analyzed due to attrition,missed visits or skipped assessments. One participant had to leave the 24 week visit before completing the ISI. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis since he completed 3 of the other assessments including the primary outcome assessment. Analyzed as intention to treat with imputation moving last value forward.
Seven psychometrically tested items on a 4 point Likert scale that measure difficulty falling asleep and staying asleep (0= none; 4=very severe) and satisfaction with current sleep patterns (0=very satisfied; 4=very dissatisfied), Noticeable impairment of quality of life (0= not noticeable; 4= very much noticeable), Worry/distress re: sleep (0=not at all worried; 4=very much worried); Interference of sleep problem to daily functioning (0=not interfering; 4= very much interfering). Scores are summed. Minimum score = 0; maximum score = 20). Higher scores denote greater insomnia severity. Scores over 14 denote insomnia; Scores 8 to 14 denote subthreshold insomnia.
Outcome measures
| Measure |
Diabetes Self Management Education (DSME) + Mind-STRIDE
n=65 Participants
Will receive routine diabetes self-management education + the Mind-STRIDE intervention
Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education
|
DSME Alone
n=67 Participants
Usual care control
|
|---|---|---|
|
Insomnia Severity Index (ISI)
Baseline
|
11.00 score on a scale
Standard Deviation 6.12
|
11.81 score on a scale
Standard Deviation 7.51
|
|
Insomnia Severity Index (ISI)
12 weeks
|
9.20 score on a scale
Standard Deviation 7.15
|
10.34 score on a scale
Standard Deviation 6.79
|
|
Insomnia Severity Index (ISI)
24 weeks
|
8.48 score on a scale
Standard Deviation 6.48
|
10.14 score on a scale
Standard Deviation 7.16
|
Adverse Events
Diabetes Self Management Education (DSME) + Mind-STRIDE
DSME Alone
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Monica DiNardo PhD, Primary Investigator
VAPHS, Center for Heath Equity Research and Promotion
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place